The Queen Alexandra Hospital, part of Portsmouth Hospitals NHS Trust in Portsmouth, England, which opened last year, has recently begun using the Biograph mCT, a hybrid PET/CT from Siemens Healthcare for research trials.
The Biograph mCT combines HD PET platform and Adaptive Spiral CT to create a dual modality device, said Siemens. The PET/CT device is currently being used by the nuclear medicine department for a series of research trials. Patient imaging, including scanning cancer patients for treatment planning, staging and management, will commence soon, added the company.
PETNet Solutions, a division of Siemens, supplies the Trust with its MetaTrace FDG biomarker for use with the Biograph mCT. It is expected that some novel biomarkers will be supplied in the near future, according to Siemens.